Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wai Chun Bio-TechnologyHKSE:00660 23 OCF Margin % is 6.36% as of Dec. 2025, which is 1574% above its 10-year median of 0.38. GuruFocus rates HKSE:00660 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,576 Chemicals companies, Wai Chun Bio-Technology ranks worse than 66.81% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Wai Chun Bio-Technology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wai Chun Bio-Technology OCF Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Wai Chun Bio-Technology's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wai Chun Bio-Technology (HKSE:00660) has a OCF Margin % of 6.36% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Wai Chun Bio-Technology and its competitors. This is 1574% above median its historical median of 0.38. According to the industry distribution chart, Wai Chun Bio-Technology ranks #1053 out of 1576 companies in the Chemicals industry, placing it in the top 66.8%.
Is Wai Chun Bio-Technology's OCF Margin % too high?
Wai Chun Bio-Technology's current OCF Margin % of 6.36% is 1574% above median its 10-year median of 0.38. The Chemicals industry median OCF Margin % is 8.36. Wai Chun Bio-Technology's value of 6.36% is 23.9% below this industry median. Based on the distribution chart, Wai Chun Bio-Technology ranks #1053 out of 1576 companies in the Chemicals industry, which is below the industry midpoint. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's OCF Margin % compare to DOW?
According to the Chemicals industry distribution chart, Wai Chun Bio-Technology ranks #1053 out of 1576 companies for OCF Margin %. This places Wai Chun Bio-Technology in the lower half of its industry. The industry median OCF Margin % is 8.36. Wai Chun Bio-Technology's value of 6.36% is 23.9% below this benchmark. While the company's 10-year median is 0.38 vs. the industry median of 8.36, Wai Chun Bio-Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Chemicals company?
The median OCF Margin % among Chemicals companies is 8.36, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wai Chun Bio-Technology's current OCF Margin % of 6.36% is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Wai Chun Bio-Technology and its competitors. For the Chemicals industry, the median OCF Margin % is 8.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wai Chun Bio-Technology's current OCF Margin % is 6.36%, which is 1574% above median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current OCF Margin % of 6.36%. The current OCF Margin % is 6.36%, which is 1574% above median its 10-year median of 0.38 and 23.9% below the Chemicals industry median of 8.36. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current OCF Margin % is 6.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score
Get the complete analysis for HKSE:00660
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00660 has been successfully added to your 
